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Spirometry Measurements During
an Episode of Exercise-Related
Transient Abdominal Pain
Darren P. Morton and Robin Callister
Purpose: To determine whether changes in lung function are associated with
exercise-related transient abdominal pain (ETAP). Methods: Twenty-eight
subjects susceptible to ETAP performed a ow-volume loop before (pre) and
after (post) treadmill exercise. Fourteen of the subjects developed symptoms of
ETAP during the exercise and completed the ow-volume loop while the pain
was present. The remaining 14 subjects reported no symptoms of ETAP. Results:
Forced inspiratory vital capacity was essentially unchanged from pre to post in
both groups (ETAP group –0.8% ± 5.1%, comparison group –0.9% ± 6.5%). Peak
inspiratory-ow rate increased in both the ETAP group (12.4% ± 16.2%) and the
comparison group (17.9% ± 16.6%), but the difference between groups (–4.6%,
standardized effect size [EF] = –0.17) was trivial. Forced expiratory vital capacity decreased by approximately 4% in both groups (ETAP group –3.9% ± 3.3%,
comparison group –4.0% ± 5.1%). Small differences in the mean change from
pre to post between groups were recorded for peak expiratory-ow rate (–7.4%,
EF = –0.28) and the forced expiratory volume in the rst second of the test
(–4.4%, EF = –0.44). Conclusions: ETAP does not appear to be associated with
reduced inspiratory performance, suggesting that the diaphragm is not implicated
directly in the etiology of ETAP. Expiratory power might be slightly reduced during
an episode of ETAP, but the magnitude of this effect is unlikely to compromise
exercise performance.
Key Words: injury management, lung function

The etiology of exercise-related transient abdominal pain (ETAP), commonly
known as stitch or side ache, has attracted much speculation. Numerous theories
have been proposed to explain ETAP, and recent attempts have been made to
evaluate the integrity of the various theories.1-4 One commonly purported origin of
the pain is the diaphragm, and indeed diaphragmatic explanations for ETAP were
among the rst to appear in the literature.5 Specically, diaphragmatic ischemia or
cramping has been argued as the cause of ETAP.5
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In 1932, a study6 conducted at Guy·s Hospital examined diaphragm function
while ETAP was being experienced in 4 males. Using uoroscopic observations,
the study reported that diaphragm function was not impaired during an episode of
the pain. Unfortunately, no spirometry or other data from this study were presented.
Nearly a decade later, Capps5 observed that the location of the pain was typically
subcostal, even naming it “subcostal pain,” and on this basis, Capps asserted that
the diaphragm was implicated. Furthermore, Capps5 argued that as the pain occurred
during exercise it was likely to be an ischemic response. Since the work of Capps5
until recent times, the diaphragm has been central to the proposed etiology of ETAP,
and sports-medicine textbooks and popular publications commonly attribute the
pain to diaphragmatic ischemia or cramping.
Recently, we provided evidence indicating that the diaphragm might not be
involved in ETAP. The pain is not conned to the subcostal region and can occur
as low in the abdomen as the iliac region.2,7,8 In addition, the pain can manifest in
activities of relatively low respiratory demand, such as horse riding2,9 and walking.8
It is also unclear how certain factors that have been demonstrated to inuence the
experience of the pain, such as the sugar content of uid consumed, could relate
to a diaphragmatic origin of the pain.10 Finally, we observed no increase in surface
electromyographic activity at the site of ETAP during an attack, despite the instrumentation being capable of measuring diaphragmatic electrophysiological output.11
The purpose of this study was to further examine the involvement of the diaphragm in the etiology of ETAP. We hypothesized that lung function, especially
inspiratory performance, would be compromised during an episode of ETAP if
the diaphragm or other muscles of respiration were involved in the etiology of
the condition. Respiratory-muscle weakness and deciency are known to result
in restricted lung function, indicated particularly in measures of vital capacity.12
Reductions in maximal ow rates are more characteristic of obstructive disorders
such as bronchospasm and decreased lung compliance.12 Hence, the aim of the present study was to determine whether spirometry changes indicative of compromised
respiratory function occur with ETAP.

Methods and Procedures
Study Design
Healthy subjects susceptible to ETAP performed a treadmill exercise session during
which lung function was assessed using a ow-volume loop on 2 occasions: before
commencing exercise and after treadmill running. Before the trial the subjects
engaged in activities designed to increase their likelihood of developing ETAP.
Subjects who experienced ETAP during the exercise constituted the ETAP group,
and those who did not report symptoms of the pain formed the comparison group.
The study design allowed comparisons to be made between the 2 groups in terms
of the prole of change in the ow-volume-loop measures.

Sample
Thirty-ve subjects who claimed to be susceptible to ETAP were initially recruited
for the study and gave their written informed consent before participating. All
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subjects were active and considered themselves to be in good physical condition.
They reported no history of respiratory dysfunction, including asthma, and were
free from symptoms of respiratory-tract infection and restriction at the time of the
laboratory testing. The study was approved by the University of Newcastle Human
Research Ethics Committee, and all research was conducted in accordance with
this body.
Twenty-one of the 35 subjects (60%) experienced ETAP during the trial. In
order for reliable testing to occur it was important that the subjects experience
a “substantial” manifestation of the pain. When subjects reported symptoms of
pain, they were asked if it was of a severity that would force them to slow down
or stop if they were performing a recreational run. Of the 21 cases in which the
pain manifested, 14 met this criterion. Thus, the symptomatic group comprised 14
subjects (ETAP group), with the 7 subjects who experienced “mild” symptoms of
ETAP being discharged from the study. The 14 subjects that did not develop the
pain still performed the testing procedures and served as the comparison group.
Personal details and baseline measures of the subjects are presented in Table 1.
The variability in the manifestation of the pain called for this unconventional
approach to allocating the subjects to the ETAP or comparison group. As seen in
Table 1, with the exception of the comparison group having a female skew, the
groups were not dissimilar.

Strategies to Provoke ETAP
The subjects were instructed to perform any procedures before arriving at the
laboratory that they believed would increase their likelihood of experiencing

Table 1 Descriptive Characteristics of Subjects and Baseline
(Preexercise) Spirometry Measures*

n
Age (y)
Male/Female
Height (cm)
Weight (kg)
BMI (kg/m)
FIVC (L)
PIF (L/min)
FEVC (L)
PEF (L/min)
FEV1.0 (L/min)

ETAP
group

Comparison
group

Combined

14
24.2 ± 5.8
11/3
175.6 ± 9.90
66.8 ± 9.3
21.6 ± 1.8
4.69 ± 0.73
7.50 ± 1.99
4.77 ± 0.80
9.80 ± 3.16
4.09 ± 0.55

14
22.2 ± 6.1
9/5
172.7 ± 7.20
63.6 ± 9.7
21.2 ± 2.5
4.93 ± 0.77
6.95 ± 2.21
5.02 ± 0.76
9.80 ± 2.51
4.10 ± 0.54

28
23.3 ± 5.90
20/8
174.2 ± 8.6 0
65.2 ± 9.40
21.4 ± 2.20
4.81 ± 0.75
7.23 ± 2.08
4.89 ± 0.78
9.80 ± 2.80
4.09 ± 0.54

*ETAP indicates exercise-related transient abdominal pain; BMI, body-mass index; FIVC, forced
inspiratory vital capacity; PIF, peak inspiratory-ow rate; FEVC, forced expiratory vital capacity; PEF,
peak expiratory-ow rate; FEV1.0, forced expiratory volume in the rst second of maximal expiration.
Data are presented as mean ± SD.
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ETAP during the testing session. For all subjects this involved consuming food
or drink shortly before the session. Before the rst ow-volume loop, the subjects were familiarized with the protocol and given between 200 and 500 mL of
carbonated soft drink. The volume depended on the amount of food and drink
already consumed by the subject. Anecdotally, soft drinks were regarded by the
subjects as particularly provocative of ETAP, which is consistent with our recent
ndings.10

Laboratory Testing Protocol
After the test brieng and tting of a heart-rate monitor (Polar Electro Oy, Model
45920, Finland) the subjects were familiarized with the ow-volume-loop test by
performing several trials. When comfortable with the procedure they completed the
rst test (pre). In order to derive a measure of test–retest reliability the subject then
performed another ow-volume loop 2 minutes later in this preexercise state. All
measures of lung function were highly reliable (P < .01), with a mean correlation
coefcient of .92 ± .02.
Treadmill velocity was then selected for the subjects according to their tness
level, with a mean velocity of 12.3 ± 1.7 km/h (range 11 to 15 km/h), which elicited
an average heart rate of 172 ± 13 beats/min. The subjects commenced exercise
on the treadmill at the set velocity and every 30 seconds were asked if they were
experiencing any symptoms of ETAP. If symptoms had developed they were asked
to rate the severity of the pain on a 10-point scale,13 from no pain (0) to pain as
bad as it could be (10). Other measures of the pain, including its localization, position, and sensation, were recorded. The sensation of the pain was recorded by the
subjects choosing a descriptor from the following 5: aching, pulling, cramping,
sharp, and stabbing. These descriptors have been shown to account for over 90%
of ETAP pain sensations.2,7
In the subjects who developed symptoms of ETAP, the test was continued until
the required severity was obtained. If the required pain severity was not obtained,
the test was terminated after 15 minutes. If the required pain severity was achieved,
the treadmill was stopped and the subjects performed the ow-volume loop (post).
The ow-volume-loop test was completed within 10 to 20 seconds of the treadmill
being stopped. On average the subjects rated the severity of ETAP as 5.1 ± 1.1
on the numerical rating scale before stopping for the ow-volume loop and 3.8 ±
1.4 immediately after the spirometry test. The severity rating of the pain after the
tests had been completed still represented a pronounced manifestation of ETAP. If
the subjects did not develop symptoms of the pain within the rst 8 to 10 minutes
of the testing session, they performed the ow-volume loop and were included as
part of the comparison group.

Spirometry Measures
A standard ow-volume loop was employed for this study, because it is a comprehensive lung-function test that assesses both expiratory and inspiratory performance. Forced expiration relies heavily on the abdominal muscles14-16 and internal
intercostal muscles,17 whereas forced inspiration recruits the diaphragm18-20 and
external intercostal muscles.17
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The test was performed on a GOULD 9000 computerized pulmonary exercise
system (GOULD, Inc, Model 229). Measures derived from the test included forced
inspiratory vital capacity, forced expiratory vital capacity (FEVC), peak inspiratoryow rate (PIF), peak expiratory-ow rate (PEF), and forced expiratory-ow rate
in the rst second of expiration (FEV1.0).

Statistical Analyses
For analysis, the 5 measures of lung function were expressed relative to height to
normalize the data.12 Analysis was then completed on the log-transformed data, with
changes expressed as percentages. A paired t test was used to determine the level of
signicance of within-group changes from pre to post. To assess between-groups
effects, we used an Excel® spreadsheet prepared by Hopkins.21 The spreadsheet
calculated the percentage change from pre to post for each subject and then performed a t test to compare the mean change between the ETAP and comparison
groups. A qualitative expression of the between-groups differences was assigned
using a modication of Cohen·s effect-size classication system.22 The terms
selected were trivial (0.0 to 0.2), small (0.2 to 0.6), moderate (0.6 to 1.2), large
(1.2 to 2.0), and very large (2.0 to 4.0).
Analysis of variance (SPSS, version 11.5) was used to determine whether the
severity of the pain was different when associated with the 5 pain descriptors used
in the study. Reliability of the ow-volume-loop measures was assessed using the
Pearson correlation coefcient. Descriptive analyses involved calculating changes
and mean ± SD. A 90% condence interval was adopted.

Results
Characteristics of ETAP
In the group that experienced ETAP during the testing session, the pain rst appeared
after 2.4 ± 1.5 minutes and was deemed of sufcient severity for testing after 7.2
± 1.8 minutes. In 1 case the subject claimed that mild pain was present after only
30 seconds of treadmill running. In most cases the pain progressively developed
until it achieved the desired severity, although in some instances it was completely
relieved while the subject continued to exercise. Although it was difcult to determine exactly, the amount of time it took after the cessation of exercise for the pain
to completely resolve was 45 seconds to 2 minutes.
Every subject who developed ETAP described the pain as well localized. In 8
of the 14 symptomatic cases, the pain was reported in more than 1 abdominal site,
but the characteristics of the pain were identical in the different positions. Exactly
half the symptomatic subjects described the pain as most severe on the right side
of the abdomen, with the other half reporting the left side.
Only 3 of the 14 subjects who developed ETAP did not change the descriptor
used to convey the sensation of the pain as the severity increased during the session. ANOVA conrmed a signicant (P < .01) difference in the severity rating
of the descriptors. Stabbing pain was associated with signicantly greater pain
severity (5.3 ± 1.5) than all other terms except sharp pain (4.6 ± 1.6). Sharp
pain was rated as more severe than aching (1.7 ± 0.9) and pulling (1.8 ± 1.2)
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but not cramping pain (3.2 ± 1.7). There was no difference among the 3 least
severe terms.

Spirometry
Within-group and between-groups changes in the spirometry measures are presented in Table 2. Trivial differences were observed between the groups in the
inspiratory measures. An increase in PIF was observed in both groups. Although
the increase in PIF was 4.6% less on average in the ETAP group, the magnitude of
the increase was highly variable, and the effect of this difference between groups
is unclear (Table 2).
FEVC decreased by approximately 4% in both groups, with only a trivial difference between them. Although there was considerable variability in the pre–post
changes in PEF and FEV1.0 in both groups, on average these values tended to
decrease in the ETAP group and increase in the comparison group. Consequently,
there were small differences between the groups for PEF and FEV1.0.

Discussion
Characteristics of ETAP
Sinclair9 claimed that, with ingestion of food or drink before exercise, ETAP
could be evoked in 30% to 35% of cases. In the present study ETAP was provoked in 60% of cases, with 40% attaining the severity required for assessment.
Allowing the subjects to select procedures to provoke the pain was clearly a
successful strategy. The consumption of carbonated soft drink shortly before
exercise appeared to be particularly provocative of ETAP, which is consistent
with a recent report that uids with high sugar content should be avoided by
susceptible individuals.10 Sinclair9 observed that after ingestion, the pain progressed from the left side of the abdomen to the right side. In the present study
there did not appear to be any pattern of progression with respect to the position
of the pain.
The characteristics of ETAP observed in the subjects who developed the
pain were consistent with our previous denition of the pain,2 namely, that it
is well localized and most prevalent in, although not conned to, the lateral
aspects of the midabdomen. The localized nature of the pain reported by every
subject in the present study is noteworthy because it suggests a somatic rather
than visceral origin.2
Although more than half the symptomatic subjects experienced ETAP in more
than 1 position, the pain description was consistent at the different sites. This
suggests that a common tissue is responsible for the pain, and the tissue must be
located throughout the entire abdomen. This observation alone provides evidence
against the pain originating from the diaphragm.
Several studies have suggested that ETAP is twice as common on the right side
of the abdomen as on the left.2,7,9 The equal distribution of right- and left-side pain
observed in the present study is likely a factor of the relatively small number of
subjects. The progression from pulling or aching to stabbing pain with increasing
severity is precisely the same as that observed in our previous work.2,7

12.4 ± 16.2

–3.9 ± 3.3

–4.3 ± 14.4

–2.9 ± 7.5

PIF (L/min)

FEVC (L)

PEF (L/min)

FEV1.0 (L/min)

1.6 ± 7.1

3.4 ± 10.7

–4.0 ± 5.1

17.9 ± 16.6

–0.9 ± 6.5

Comparison
group

–4.4 (0.1 to –8.6)

–7.4 (–14.3 to 0.0)

0.1 (–2.6 to 2.9)

–4.6 (–13.5 to 5.2)

0.1 (–3.5 – 3.9)

% Difference in means
between groups (90% CL)

0.10

0.10

0.95

0.42

0.62

P

–0.44 (–0.88 to 0.01) 0

–0.28 (–0.55 to 0.00) 0

0.01 (–0.21 to 0.22) 0

–0.17 (–0.53 to 0.19) 0

0.01 (–0.28 to 0.30) 0

ES (90% CL)

small

small

trivial

trivial

trivial

Descriptor

*ETAP indicates exercise-related transient abdominal pain; CL, condence limits; ES, effect size; FIVC, forced inspiratory vital capacity; PIF, peak inspiratory-ow

–0.8 ± 5.1

ETAP group

% Change Pre to Post

Within- and Between-Groups Changes in the Spirometry Measures From Pre to Post*

FIVC (L)

Table 2
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Breathing maneuvers including deep exhalation, forced exhalation, “belly
breathing,” and shallow respirations have been proposed to facilitate the relief
of ETAP.23-25 Although a decrease in pain severity was noted over the duration
of the spirometry assessment, the pain subsides quickly when activity is ceased,
regardless. Hence is not possible to determine from these data whether the
breathing maneuvers of the ow-volume loop facilitated the pain relief.

Spirometry
The present study was unconventional in its approach to measuring exercise-related
changes in spirometry in that the posttesting occurred immediately after the subject ceased exercise so that we could take the measurements while the pain was
present. Many studies have examined the magnitude of exercise-induced changes
in lung function in both normal and asthmatic populations, but the convention,
recommended by the American Thoracic Society, is to perform initial posttesting
10 minutes after exercise has been terminated.26-28 Studies have required subjects to
perform posttests as soon as 4 minutes after exercise,26 but immediately postexercise
data are not available for trend comparison with the present study.
When the 10-minute postexercise protocol is adopted, decreases in spirometry measures of more than 10% are typically considered functionally signicant
and indicative of obstructive disorders such as bronchospasm,26,28 and it has been
suggested that this criterion should be reduced to as low as 6% to 7% for the elite
athletic population.26,28 In neither group did the mean within-group changes in the
present study meet either of these criteria, although 2 individuals in each group
did. This compromise in lung function in these individuals does not appear to be
related to the presence of ETAP because it was also observed in the comparison
group and might simply reect mild undiagnosed postexercise bronchospasm in
these individuals.
In the postexercise test, both groups demonstrated a substantial increase in
PIF and a slight decrease in FEVC. The increase in PIF could be explained by an
increased lung compliance associated with exercise-induced surfactant production.29
The small decrease in FEVC might have been the result of the subjects· nding
the ow-volume loop challenging when performed immediately after ceasing the
treadmill exercise. The subjects· ventilations were high at this time, and for this
reason they found it taxing to hold the forced expiration for the 5 seconds required
by the testing protocol.
The analyses most relevant to the primary focus of the present study are the
comparison data between the groups because they enable the effect of ETAP to
be elucidated. Clearly, the episode of ETAP did not result in substantial effects on
inspiratory or expiratory capacity. Although there was an average of 4.6% difference in the increase in PIF pre–post between the groups, both groups increased
considerably more than 4.6% from pre to post. This suggests that ETAP is unlikely
to result in a restrictive impairment of lung function.
In terms of an obstructive respiratory disorder, the between-groups differences in the expiratory measures are of interest. Similar reductions in FEVC
postexercise were observed in both groups, but on average, the ETAP group
experienced a reduction in PEF and FEV1.0 after exercise, whereas the comparison
group improved. If this is a real effect attributable to ETAP and not merely some
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individuals experiencing mild postexercise bronchospasm, 2 explanations seem
plausible for a possible reduction in expiratory power associated with ETAP.
First, the pain being experienced in the ETAP group might have an effect on
forced expiration. Immediate, sudden pain can cause acute apnea, but little
information is available on the effect of more persistent pain on spirometry
measures. Pain is typically associated with some pathology, and separating
the 2 is difcult if not impossible. The second possible explanation is that
the mechanism responsible for ETAP imposes obstructive limitations on lung
function. FEV1.0 and PEF can be reduced by an increase in airway resistance or
a decrease in the lung·s elastic recoil.12 A mechanism for such acute obstructive changes is unclear, and if this is the case, it is also unclear why expiratory
capacity (FEVC) is unaffected.
The measures of inspiratory performance were the most relevant to the primary
aim of the present study because inspiration is dominated by diaphragm activity.1820
The results suggest that inspiratory performance is unlikely to be compromised
during an episode of ETAP, indicating that diaphragm function is not substantially
impaired during an episode of ETAP. This observation is consistent with the Guy·s
Hospital report.6 Compromised diaphragm function would be anticipated if the
diaphragm were anoxic or in spasm, which is commonly asserted as the mechanism
responsible for ETAP.

Practical Applications
The following practical applications arise from the present study:
• Carbonated drinks with high sugar content appear to be highly provocative of
ETAP. Hence, these uids should be avoided by individuals prone to ETAP to
reduce their likelihood of experiencing the pain. Conversely, the use of these
uids is of value to researchers wanting to evoke the pain for investigative
purposes.
• Diminished exercise performance associated with ETAP is not likely the result
of compromised lung function.
• Because diaphragm function is not substantially affected during an attack
of ETAP, pain-management strategies specically designed to target the
diaphragm are likely to be ineffective. Such procedures have included “belly
breathing,” in which the abdomen is distended during inspiration; deep breathing; and forced expiration through pursed lips. If these techniques assist with
pain relief it would seem that their effect is for reasons other than their inuence on the diaphragm.

Conclusions
The ndings of the present study indicate that diaphragm function is unlikely to
be compromised during an episode of ETAP, which is enlightening with respect
to the etiology of the pain. Whether the abdominal muscles are implicated in the
pain requires further investigation.
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